Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
GUIDELINES/RECOMMENDATIONS
Polish consensus on smoking cessation intervention within lung cancer screening
1
Division of Public Health and Social Medicine, Faculty of Medicine, Medical University of Gdansk, Poland
2
2nd Division of Radiology, Faculty of Medicine, University Clinical Center, Medical University of Gdansk, Gdańsk, Poland
3
Department of Thoracic Surgery, University Clinical Center, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland
4
Department of Epidemiology and Cancer Prevention, Maria Skłodowska-Curie National Research Institute of Oncology
5
Department of Lung Diseases and Respiratory Failure, Kuyavian-Pomeranian Pulmonology Center
6
Department of Prevention and Medical Education, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland
7
Department of Oncology and Radiotherapy, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland
Submission date: 2025-07-29
Final revision date: 2025-10-23
Acceptance date: 2025-11-09
Online publication date: 2025-12-19
Corresponding author
Krzysztof Bartosz Klimiuk
2nd Division of Radiology Faculty of Medicine University Clinical Center Medical University of Gdansk, Poland
2nd Division of Radiology Faculty of Medicine University Clinical Center Medical University of Gdansk, Poland
KEYWORDS
TOPICS
ABSTRACT
Lung cancer, the leading cause of cancer-related deaths globally and in Poland, accounts for 25% of all cancer-related deaths, with smoking being its predominant cause. While primary prevention through smoking cessation is crucial, the effectiveness of lung cancer screening (LCS) with low-dose computed tomography in reducing mortality has gained international recognition. This expert consensus, developed through multidisciplinary collaboration, proposes a comprehensive framework for smoking cessation interventions within LCS. Key recommendations include providing participants with educational materials, cognitive-behavioral counseling, and pharmacotherapy. Proactive follow-up, biochemical addiction validation, and teleconsultations are essential to ensure long-term cessation. Besides, participants should be discouraged from using alternative nicotine products, such as heated tobacco or electronic cigarettes due to their limited efficacy, highly probable health risks and potential for nicotine addiction. By integrating evidence-based cessation methods, LCS programs can serve as a model for broader smoking cessation strategies in healthcare.
REFERENCES (64)
1.
SEER Cancer Stat Facts: Lung and Bronchus Cancer. National Cancer Institute. Bethesda, MD,. https://seer.cancer.gov/statfa....
3.
Thandra KC, Barsouk A, Saginala K, et al. Epidemiology of lung cancer. Contemp Oncol 2021; 25: 45-52.
4.
Tang S, Meng J, Zhao X, Sun W. Trends of ischemic heart disease mortality attributable to smoking in the five countries with the highest number of smokers during 1990–2019: an age-period-cohort analysis. Arch Med Sci 2024; 20: 43-53.
5.
De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. Lancet Oncol 2014; 15: 23-34.
6.
Zappa C, Mousa SA. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res 2016; 5: 288-300.
7.
Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 2018; 391: 1023-75.
8.
Didkowska JA, Barańska K, Miklewska MJ, Wojciechowska U. Cancer incidence and mortality in Poland in 2023. Nowotwory 2024; 74: 75-93.
9.
Jankowski M, Ostrowska A, Sierpiński R, et al. The prevalence of tobacco, heated tobacco, and e-cigarette use in Poland: a 2022 Web-Based Cross-Sectional Survey. Int J Environ Res Public Health 2022; 19: 4904.
10.
Balwicki Ł, Miller M, Cedzyńska M, et al. Expert consensus statement on tobacco control sustainability in Poland. Nowotwory 2023; 8: 292-5.
11.
Adamek M, Biernat W, Chorostowska-Wynimko J, et al. Lung cancer in Poland. J Thorac Oncol 2020; 15: 1271-6.
12.
Maciejczyk A, Zawadzki P, Karczewicz E, et al. Straty ekonomiczne i koszty leczenia wybranych ośmiu nowotworów w województwie dolnośląskim w latach 2014-2016 – wnioski dla polityki zdrowotnej. 2018.
13.
Yu S, Yang L, Xu W, et al. Analysis of tracheal, bronchial, and lung cancer attributable to respiratory system-related risk factors in 204 countries and territories from 1990 to 2019. Arch Med Sci 2024; 20: 1495-503.
14.
De Koning H, Van Der Aalst C, Ten Haaf K, Oudkerk M. PL02.05 Effects of volume CT lung cancer screening: mortality results of the NELSON randomised-controlled population based trial. J Thorac Oncol 2018; 13: S185.
16.
Słomska E, Niemczyk-Szechowska P, Ryś P, et al. Rak Płuca-2021. Leczenie farmakologiczne. Warszawa, 2021.
17.
Gatsonis CA, Aberle DR, Berg CD, et al. The national lung screening trial: overview and study design. Radiology 2011; 258: 243-53.
18.
Search for: smoking cessation | List Results | ClinicalTrials.gov. https://clinicaltrials.gov/sea....
19.
Van Der Aalst CM, Van Klaveren RJ, Van Den Bergh KAM, et al. The impact of a lung cancer computed tomography screening result on smoking abstinence. Eur Respir J 2011; 37: 1466-73.
20.
Ashraf H, Tønnesen P, Holst Pedersen J, et al. Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST). Thorax 2009; 64: 388-92.
21.
Van Der Aalst CM, Van Den Bergh KAM, Willemsen MC, et al. Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial. Thorax 2010; 65: 600-5.
22.
Ashraf H, Saghir Z, Dirksen A, et al. Smoking habits in the randomised Danish Lung Cancer Screening Trial with low-dose CT: final results after a 5-year screening programme. Thorax 2014; 69: 574-9.
23.
Cinciripini PM, Minnix JA, Kypriotakis G, et al. Smoking cessation interventions in the lung cancer screening setting: a randomized clinical trial. JAMA Intern Med 2025; 185: 284-91.
24.
Taylor KL, Hagerman CJ, Luta G, et al. Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting: a randomized clinical trial. Lung Cancer 2017; 108: 242-6.
25.
Tremblay A, Taghizadeh N, Huang J, et al. A randomized controlled study of integrated smoking cessation in a Lung Cancer Screening Program. J Thorac Oncol 2019; 14: 1528-37.
26.
Gendy MNS, Ibrahim C, Sloan ME, Le Foll B. Randomized clinical trials investigating innovative interventions for smoking cessation in the last decade. Handb Exp Pharmacol 2020; 258: 395-420.
27.
Foley KL, Dressler EV, Weaver KE, et al. The Optimizing Lung Screening Trial (WF-20817CD): Multicenter randomized effectiveness implementation trial to increase tobacco use cessation for individuals undergoing lung screening. Chest 2023; 164: 531-43.
28.
Murray RL, Alexandris P, Baldwin D, et al. Uptake and 4-week quit rates from an opt-out co-located smoking cessation service delivered alongside community-based low-dose computed tomography screening within the Yorkshire Lung Screening Trial. Eur Respir J 2024; 63: 2301768.
29.
Taylor KL, Williams RM, Li T, et al. A randomized trial of telephone-based smoking cessation treatment in the lung cancer screening setting. J Natl Cancer Inst 2022; 114: 1410-9.
30.
Evans WK, Tammemägi MC, Walker MJ, et al. Integrating smoking cessation into low-dose computed tomography lung cancer screening: results of the Ontario, Canada Pilot. J Thorac Oncol 2023; 18: 1323-1333.
31.
Courtney RJ, McRobbie H, Tutka P, et al. Effect of cytisine vs varenicline on smoking cessation: a randomized clinical trial. JAMA 2021; 326: 56-64.
32.
Oreskovic T, Percac-Lima S, Ashburner JM, et al. Cytisine versus varenicline for smoking cessation in a primary care setting: a randomized non-inferiority trial. Nicotine Tob Res 2023; 25: 1547-55.
33.
Walker N, Smith B, Barnes J, et al. Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial. Addiction 2021; 116: 2847-58.
34.
Pastorino U, Ladisa V, Trussardo S, et al. Cytisine therapy improved smoking cessation in the randomized screening and multiple intervention on lung epidemics lung cancer screening trial. J Thorac Oncol 2022; 17: 1276-86.
35.
Williams PJ, Philip KEJ, Alghamdi SM, et al. Strategies to deliver smoking cessation interventions during targeted lung health screening – a systematic review and meta-analysis. Chron Respir Dis 2023; 20: 14799731231183446.
36.
Cadham CJ, Jayasekera JC, Advani SM, et al. Smoking cessation interventions for potential use in the lung cancer screening setting: a systematic review and meta-analysis. Lung Cancer 2019; 135: 205-16.
37.
Baldwin DR, O’Dowd EL, Tietzova I, et al. Developing a pan-european technical standard for a comprehensive high-quality lung cancer CT screening program. An ERS Technical Standard. Eur Respir J 2023; 61: 2300128.
38.
Bała MM, Cedzyńska M, Balwicki Ł, et al. Wytyczne leczenia uzależnienia od nikotyny. Medycyna Praktyczna. 2022.
39.
Rzyman W, Didkowska J, Dziedzic R, et al. Consensus statement on a screening programme for the detection of early lung cancer in Poland. Adv Respir Med 2018; 86: 53-74.
40.
Raja M, Saha S, Mohd S, et al. Cognitive behavioural therapy versus basic health education for tobacco cessation among tobacco users: a randomized clinical trail. J Clin Diagn Res 2014; 8: ZC47-9.
41.
Lindson-Hawley N, Thompson TP, Begh R. Motivational interviewing for smoking cessation. Cochrane Database Syst Rev 2015; 3: CD006936.
42.
Cinciripini PM, Kypriotakis G, Green C, et al. The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: a randomized clinical trial. Depress Anxiety 2022; 39: 429-40.
43.
Richmond RL, Harris K, De Almeida Neto A. The transdermal nicotine patch: results of a randomised placebo-controlled trial. Med J Australia 1994; 161: 130-5.
44.
Míguez MC, Vázquez FL, Becoña E. Effectiveness of telephone contact as an adjunct to a self-help program for smoking cessation: a randomized controlled trial in Spanish smokers. Addict Behav 2002; 27: 139-44.
45.
Chen YF, Madan J, Welton N, et al. Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis. Health Technol Assess (Rockv) 2012; 16: 1-205.
46.
Balwicki Ł, Cedzyński M, Koczkodaj P, et al. Rekomendacje w Zakresie Ochrony Dzieci i Młodzieży przed Konsekwencjami Używania Produktów Nikotynowych. Warszawa, 2020.
47.
Behavioral Research Program|Division of Cancer Control and Population Sciences (DCCPS). https://cancercontrol.cancer.g....
48.
Catley D, Grobe J, Moreno JL, et al. Differential mechanisms of change in motivational interviewing versus health education for smoking cessation induction. Psychol Addict Behav 2021; 35: 778-87.
49.
Aveyard P, Massey L, Parsons A, et al. The effect of Transtheoretical Model based interventions on smoking cessation. Soc Sci Med 2009; 68: 397-403.
50.
West R, Zatonski W, Cedzynska M, et al. Placebo-controlled trial of cytisine for smoking cessation. N Engl.J Med 2011; 365: 1193-200.
51.
Maskrey V, Blyth A, Brown TJ, et al. Self-help educational booklets for the prevention of smoking relapse following smoking cessation treatment: a randomized controlled trial. Addiction 2015; 110: 2006-14.
52.
Windle SB, Filion KB, Mancini JG, et al. Combination therapies for smoking cessation: a hierarchical bayesian meta-analysis. Am J Prev Med 2016; 51: 1060-71.
53.
Sealock T, Sharma S. Smoking Cessation. StatPearls Treasure Island (FL) StatPearls Publishing 2023.
54.
Richardson S, McNeill A, Brose LS. Smoking and quitting behaviours by mental health conditions in Great Britain (1993-2014). Addict Behav 2019; 90: 14-9.
55.
Hemanath S H, Robinson F, Pang NTP, et al. Mindfulness-based therapy for smoking cessation and mental health: a randomised controlled trial. Med J Malaysia 2023; 78: 336-43.
56.
Carrasco-Hernandez L, Jódar-Sánchez F, Núñez-Benjumea F, et al. A mobile health solution complementing psychopharmacology-supported smoking cessation: randomized controlled trial. JMIR Mhealth Uhealth 2020; 8: e17530.
57.
Theodoulou A, Chepkin SC, Ye W, et al. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2023; 2023: CD013308.
58.
Swan GE, McClure JB, Jack LM, et al. Behavioral counseling and varenicline treatment for smoking cessation. Am J Prev Med 2010; 38: 482-90.
59.
Hughes JR, Stead LF, Hartmann-Boyce J, et al. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2014; 2014: CD000031.
60.
Westergaard CG, Porsbjerg C, Backer V. The effect of Varenicline on smoking cessation in a group of young asthma patients. Respir Med 2015; 109: 1416-22.
61.
Jordan CJ, Xi ZX. Discovery and development of varenicline for smoking cessation. Expert Opin Drug Discov 2018; 13: 671-83.
62.
Jiménez-Ruiz CA, Riesco Miranda JA, Martínez Picó A, et al. The DESTINA Study: an observational cross-sectional study to evaluate patient satisfaction and tolerability of cytisine for smoking cessation in Spain. Arch Bronconeumol 2023; 59: 270-2.
63.
Phusahat P, Dilokthornsakul P, Boonsawat W, et al. Efficacy and safety of cytisine in combination with a community pharmacists’ counselling for smoking cessation in Thailand: a randomized double-blinded placebo-controlled trial. Int J Environ Res Public Health 2022; 19: 13358.
64.
Nides M, Rigotti NA, Benowitz N, et al. A multicenter, double-blind, randomized, placebo-controlled phase 2b trial of cytisinicline in adult smokers (The ORCA-1 Trial). Nicotine Tob Res 2021; 23: 1656-63.
Share
RELATED ARTICLE
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
